We show that, compared with surgeon predictions and existing risk-prediction tools, our machine-learning model can enhance ...

In phase 2a study, brivekimig led to clinically meaningful improvements in primary and key secondary endpoints in biologic-naïve patients compared to placebo at week 16 Dual-target Nanobody® VHH ...

EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study In phase 2a study, brivekimig led to clinically meaningful improvements in primary and key secondary ...

Abstract: Blockchain has found many uses beyond cryptocurrency trading. However, this technology faces the challenge of low transactions per second (TPS), which hinders it from competing at scale with ...

Empowered by technological progress, sports teams and bookmakers strive to understand relationships between player and team activity and match outcomes. For this purpose, the probability of an event ...

For this project we have chosen a dataset, sourced from the National Institute of Diabetes and Digestive and Kidney Diseases, that aims to predict the likelihood of diabetes in patients based on ...